Joe is becoming an unreliable CEO, unable to execu

Joe is becoming an unreliable CEO, unable to execute past PR's, it's great to work on Covid but 4 months ago we only talked about Generex and NGIO........ little progress unless the good news is "non public info". More litigation by potential funding resources, usual missed timelines creating unfavorable "note" conversions. Total outstanding shares have increased because of poor negotiated deals, unrealistic expectations and poor agreements to protect shareholders dividend. World Class Management learning on the job , no cash to close deals, Altucell pending (if still around), China slow to transfer funds ( or paid in rice), AE37 still recruiting - I assume no funds to recruit all 29 patients.
Solid Management would have built on PR's and execute announced plans to maintain a steady pps Time is not our friend , current due diligence will indicate shaky deals and risky investment based on Management past history. Pretty soon Covid will turn into a story of the past, an opportunity to benefit will diminish and big pharma will flood the market with antibody and vaccines. If NASDAQ is the main priority I can imagine where we are with the spin-off, MSO/HMO and additional acquisitions. Looking forward to Q3 filing, should be any day now !!